Tab. III.
Strategies for preventing rubella and CRS – Surveillance.
| References | Authors / Strategies | Surveillance | ||
|---|---|---|---|---|
| Underestimation of R and CRS | Laboratories’ role | Integrating MR | ||
| 9 | Jin 2007 | x | ||
| 11 | Carnicer-Pont 2008 | x | ||
| 12 | CDC 2008 | x | x | |
| 13 | Weekly epidemiological record 2008 | x | x | |
| 14 | Canepa 2009 | x | ||
| 15 | Forsey 2009 | x | ||
| 17 | Martin 2009 | x | ||
| 19 | Pandolfi 2009 | x | ||
| 20 | Bisbo de Filippis 2011 | x | x | |
| 21 | Castillo-Solorzano 2011 | x | x | |
| 24 | Rota 2011 | x | ||
| 25 | Usonis 2011 | x | x | |
| 26 | Zimmerman 2011 | x | x | x |
| 27 | Zimmerman Muscat 2011 | x | x | x |
| 28 | Bechini 2012 | x | ||
| 30 | Goodson 2012 | x | ||
| 34 | Barrabeig 2013 | x | x | |
| 35 | Bechini 2013 | x | x | |
| 36 | Buffolano 2013 | x | ||
| 37 | CDC 2013 | x | x | |
| 41 | Paradowska-Stankievicz 2013 | x | ||
| 6 | Bouthry 2014 | x | x | |
| 44 | Khandaker 2014 | x | ||
| 47 | Chan 2015 | x | ||
| 49 | Giambi 2015 | x | x | |
| 50 | Giambi Filia 2015 | x | x | |
| 52 | Martinez-Quintana 2015 | x | x | |
| 53 | Masa Calles 2015 | x | x | |
| 54 | Neu 2015 | x | ||
| 55 | Plans 2015 | x | ||
| 56 | Sugishita 2015 | x | x | |
| 60 | Paradowska-Stankievicz 2016 | x | ||
| 61 | Vynnycky 2016 | x | ||
| 4 | Grant 2017 | x | ||
| 65 | Edirisuriya 2018 | x | ||
| 68 | Seppälä 2018 | x | x | |